New York Daily News
<img alt="" height="1" width="1" />
J&J to pay $2.2B in drug marketing penalties
USA TODAY
Johnson & Johnson has agreed to pay more than $2.2 billion to settle criminal and civil claims that it marketed the antipsychotic drug Risperdal and other medications for off-label uses and paid kickbacks to a large pharmacy, the Justice Department said ...
Johnson & Johnson Slapped with $2.2 Billion Fine for Deceptive MarketingTrade the Newsroom
Missouri to receive $26 million through drug settlementSTLtoday.com
Ohio gets $52.7 mil share of drug settlementWKEF ABC 22
WCBE 90.5 FM -New York Times -MediaPost Communications
all 246 news articles »
More...